Product
Neoadjuvant
1 clinical trial
2 indications
Indication
Hepatocellular CarcinomaIndication
Portal Vein Tumour ThrombosisClinical trial
Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy Prior to Hepatectomy in Hepatocellular Carcinoma With Portal Vein Tumour Thrombus (ADVANCE HCC) Hoffmann La Roche Protocol Number: ML42525Status: Recruiting, Estimated PCD: 2026-06-30